Although the function of IGF2BP3 in a variety of cancers has been preliminarily revealed, its specific mechanism of action in lung adenocarcinoma and the clinical relevance of IGF2BP3 remain to be fully elucidated through additional research. This evidence concerns the gene IGF2BP3 and lung adenocarcinoma.